Quick Answer
AIM ImmunoTech Inc. reported Long-Term Debt of $1.88 million for fiscal year 2020.
AIM ImmunoTech Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2020 | $1.88M | -10.8% |
| 2019 | $2.10M | -9.2% |
| 2018 | $2.32M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| March 31, 2021 | $1.82M | -11.4% | -3.2% |
| December 31, 2020 | $1.88M | -10.8% | -3.0% |
| September 30, 2020 | $1.93M | -10.4% | -3.0% |
| June 30, 2020 | $1.99M | -9.9% | -2.8% |
| March 31, 2020 | $2.05M | -9.6% | -2.6% |
| December 31, 2019 | $2.10M | -9.2% | -2.5% |
| September 30, 2019 | $2.16M | -8.9% | -2.5% |
| June 30, 2019 | $2.21M | -8.4% | -2.4% |
- AIM ImmunoTech Inc. showed a decrease of -10.8% in Long-Term Debt compared to the prior fiscal year.
- Over the 2018–2020 period, AIM ImmunoTech Inc.’s long-term debt has declined by 19.1% (from $2.32 million to $1.88 million).
- The most recent figure is from AIM ImmunoTech Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 31, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: